Abstract:Nanoparticles (NPs) that are ∼100 nm in diameter can potentially cause toxicity in the central nervous system (CNS). Although NPs exhibit positive aspects, these molecules primarily exert negative or harmful effects. Thus, the beneficial and harmful effects should be compared. The prevalence of neurodegenerative diseases, such as Alzheimer disease, Parkinson disease, and some brain tumors, has increased. However, the major cause of these diseases remains unknown. NPs have been considered as one of the major potential causes of these diseases, penetrating the human body via different pathways. This review summarizes various pathways for NP-induced neurotoxicity, suggesting the development of strategies for nanoneuroprotection using in silico and biological methods. Studies of oxidative stress associated with gene expression analyses provide efficient information for understanding neuroinflammation and neurodegeneration associated with NPs. The brain is a sensitive and fragile organ, and evolution has developed mechanisms to protect it from injury; however, this protection also hinders the methods used for therapeutic purposes. Thus, brain and CNS-related diseases that are the cause of disability and disorder are the most difficult to treat. There are many obstacles to drug delivery in the CNS, such as the blood brain barrier and blood tumor barrier. Considering these barriers, we have reviewed the strategies available to map NPs using biological techniques. The surface adsorption energy of NPs is the basic force driving NP gathering, protein corona formation, and many other interactions of NPs within biological systems. These interactions can be described using an approach named the biological surface adsorption index. A quantitative structural activity relationship study helps to understand different protein-protein or protein-ligand interactions. Moreover, equilibrium between cerebrovascular permeability is required when a drug is transferred via the circulatory system for the therapy of neurodegenerative diseases. Various drug delivery approaches, such as chemical drug delivery and carrier-mediated drug delivery, have been established to avoid different barriers inhibiting CNS penetration by therapeutic substances. Developing an improved understanding of drug receptors and the sites of drug action, together with advances in medicinal chemistry, will make it possible to design drugs with greatly enhanced activity and selectivity; this may result in a significant increase in the therapeutic index.

Engineered nanoparticles. How brain friendly is this new guest?

Impact of nanoparticles on human health and disease

Nanoneurotoxicity to Nanoneuroprotection Using Biological and Computational Approaches

Nanoneurotoxicity to nanoneuroprotection using biological and computational approaches.

Nervous System Exposure of Different Classes of Nanoparticles: A Review on Potential Toxicity and Mechanistic Studies

The Effects of Micro- and Nanoplastics on the Central Nervous System: A New Threat to Humanity?

Neurotoxicities induced by micro/nanoplastics: A review focusing on the risks of neurological diseases

The neurotoxicity induced by engineered nanomaterials.

Toxicological Considerations, Toxicity Assessment, and Risk Management of Inhaled Nanoparticles

The Effects of Nanoplastics on the Dopamine System of Cerebrocortical Neurons

Neurotoxicity concern about the brain targeting delivery systems

A review on potential neurotoxicity of titanium dioxide nanoparticles

An updated overview of some factors that influence the biological effects of nanoparticles

Molecular mechanisms of zinc oxide nanoparticles neurotoxicity

Navigating the nano-bio immune interface: advancements and challenges in CNS nanotherapeutics

Recent Status of Nanomaterial Fabrication and Their Potential Applications in Neurological Disease Management

Navigating Neurotoxicity and Safety Assessment of Nanocarriers for Brain Delivery: Strategies and Insights

Paracrine signalling of inflammatory cytokines from an in vitro blood brain barrier model upon exposure to polymeric nanoparticles

Review of the effects of manufactured nanoparticles on mammalian target organs.

Nano-Neurotheranostics: Impact of Nanoparticles on Neural Dysfunctions and Strategies to Reduce Toxicity for Improved Efficacy

Potential neurotoxicity of nanoparticles.